Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antidepressant Treatment Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT00221494
What this trial is testing

Can Additional Drug Therapy Accelerate Response Time to Antidepressants

Who this might be right for
Depression
Mark Frye
Post-approval studies (Phase 4)Study completedNCT00352885
What this trial is testing

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Who this might be right for
Depression
Emory University 20
Not applicableLooking for participantsNCT05616559
What this trial is testing

Precision Medicine in the Depression Treatment

Who this might be right for
Depressive Disorder, MajorTreatment OutcomeCognitive Dysfunction+2 more
Rigshospitalet, Denmark 800
Not applicableStudy completedNCT01454635
What this trial is testing

Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Showa University 96
Post-approval studies (Phase 4)Study completedNCT00792168
What this trial is testing

Physiologic Monitoring of Antidepressant Response

Who this might be right for
Major Depression
University of California, Los Angeles 38
Testing effectiveness (Phase 2)UnknownNCT04171193
What this trial is testing

Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent

Who this might be right for
Depressive Disorder, MajorTreatment Resistant DepressionDepressive Episode
University of Sao Paulo 30
Post-approval studies (Phase 4)Study completedNCT00308893
What this trial is testing

BDNF Gene Polymorphism and Antidepressants Treatment

Who this might be right for
Depression
University Hospital, Tours 188
Large-scale testing (Phase 3)Study completedNCT02272517
What this trial is testing

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 101
Post-approval studies (Phase 4)Study completedNCT02132286
What this trial is testing

Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression

Who this might be right for
Major Depressive Disorder
University of Calgary 57
Post-approval studies (Phase 4)Study completedNCT00519428
What this trial is testing

Does Dual Therapy Hasten Antidepressant Response?

Who this might be right for
Major Depressive Disorder
New York State Psychiatric Institute 245
Large-scale testing (Phase 3)Not Yet RecruitingNCT07781293
What this trial is testing

Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy

Who this might be right for
Major Depressive Disorder (MDD)Major Depressive Disorder With Psychotic Features
Bukwang Pharmaceutical 364
Large-scale testing (Phase 3)Study completedNCT05550532
What this trial is testing

Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 444